SEC Form 4 · accession 0001179110-16-030045
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Gregory Almstead
Officer — EVP Research Pharma Ops & Tech
Period of report
Sep 27, 2016
Accepted (ET)
Sep 27, 2016 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 27, 2016 | M | 3,414 | $10.85 | A | 3,414 | D | |
| Common Stock | Sep 27, 2016 | M | 6,586 | $10.85 | A | 10,000 | D | |
| Common Stock | holding | — | — | — | 1,295 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.85 | Sep 27, 2016 | M | 3,414 | D | — | May 15, 2023 | Common Stock | 3,414 | 66,898 | D |
| Stock Option (Right to Buy)F2 | $10.85 | Sep 27, 2016 | M | 6,586 | D | — | May 15, 2023 | Common Stock | 6,586 | 3,102 | D |
| Stock Option (Right to Buy)F3 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 40,000 | 40,000 | D |
| Stock Option (Right to Buy)F4 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 69,550 | 69,550 | D |
| Stock Option (Right to Buy)F5 | $30.86 | holding | — | — | — | — | Jan 3, 2026 | Common Stock | 55,000 | 55,000 | D |
| Stock Option (Right to Buy)F7 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 166 | 166 | D |
| Stock Option (Right to Buy)F7 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 216 | 216 | D |
| Stock Option (Right to Buy)F7 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 200 | 200 | D |
| Stock Option (Right to Buy)F7 | $451.20 | holding | — | — | — | — | May 15, 2019 | Common Stock | 200 | 200 | D |
| Stock Option (Right to Buy)F7 | $735.60 | holding | — | — | — | — | Apr 1, 2018 | Common Stock | 194 | 194 | D |
| Stock Option (Right to Buy)F7 | $735.60 | holding | — | — | — | — | Jan 25, 2018 | Common Stock | 166 | 166 | D |
| Stock Option (Right to Buy)F7 | $626.40 | holding | — | — | — | — | Apr 18, 2017 | Common Stock | 137 | 137 | D |
| Stock Option (Right to Buy)F7 | $10.85 | holding | — | — | — | — | May 15, 2023 | Common Stock | 600 | 600 | I |
| Stock Option (Right to Buy)F7 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 1,300 | 1,300 | I |
| Stock Option (Right to Buy)F7 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 2,060 | 2,060 | I |
| Restricted Stock UnitF6 | — | holding | — | — | — | — | — | Common Stock | 750 | 750 | I |
| Stock Option (Right to Buy)F7 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 7 | 7 | I |
| Stock Option (Right to Buy)F7 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 7 | 7 | I |
| Stock Option (Right to Buy)F7 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 1 | 1 | I |
| Stock Option (Right to Buy)F7 | $508.80 | holding | — | — | — | — | Oct 7, 2019 | Common Stock | 12 | 12 | I |
Explanation of responses
- F1This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on June 15, 2014.
- F2This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on January 31, 2014.
- F3This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- F4This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
- F5This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
- F6This restricted stock unit (RSU) award was granted on January 4, 2016 and vests in equal installments over four years on each anniversary of the grant date. Upon vesting, each RSU will convert into one share of common stock of the Issuer.
- F7Currently exercisable.